Hybio Pharmaceutical Market Cap

Hybio Pharmaceutical has a market cap or net worth of 18.18 billion as of June 9, 2026. Its market cap has increased by 44.12% in one year.

Market Cap

18.18B

Enterprise Value

20.04B

Revenue

955.53M

Ranking

n/a

PE Ratio

201.23

Stock Price

21.43

Market Cap Chart

Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 18.18B, an increase of 520.38%. That is a compound annual growth rate of 12.77%.

Market Cap History

Date	Market Cap	% Change
Jun 9, 2026	18.93B	19.72%
Dec 31, 2025	15.81B	38.87%
Dec 31, 2024	11.38B	-5.08%
Dec 29, 2023	11.99B	-22.75%
Dec 30, 2022	15.53B	39.41%
Dec 31, 2021	11.14B	88.22%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Kangmei Pharmaceutical	20.88B
Betta Pharmaceuticals	20.57B
Jilin Aodong Pharmaceutical Group	19.90B
Chengdu Kanghong Pharmaceutical Group	19.65B
Jiangsu Nhwa Pharmaceutical Co., LTD	19.62B
Walvax Biotechnology	18.92B
Guangdong Zhongsheng Pharmaceutical	18.59B
Dizal (Jiangsu) Pharmaceutical	18.37B

Market Cap Rankings